Survival impact of unexpected N2 in stage IIIB/N2 non-small cell lung cancer patients.
Volkan ErdoğuNecati ÇıtakCelal Buğra SezenDilekhan KizirGamze TanrıkuluMustafa Vedat DoğruYunus SeyrekLevent CanseverÖzkan SaydamMuzaffer MetinPublished in: Asian cardiovascular & thoracic annals (2023)
In stage IIIB/N2 cases, the fact that N2 could not be detected preoperatively with minimally invasive or invasive methods and was detected in the pathological examination after surgery does not provide a survival advantage.